Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-017005
Filing Date
2025-06-27
Accepted
2025-06-27 20:45:26
Documents
1
Period of Report
2025-06-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3718
  Complete submission text file 0001641172-25-017005.txt   5404
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TESARO, INC. 1000 WINTER ST., SUITE 3300 WALTHAM MA 02451
Business Address
Armitage James O (Reporting) CIK: 0001370087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 251088536